比较激光解剖内镜下前列腺摘除(LAEEP)和经尿道前列腺切除术(TURP)治疗前列腺增生症的疗效:一项荟萃分析

Dimas B. Kresna Yustisia Handoyo , Boyke Soebhali , Widiyanto Prasetyawan , Probo Yudha Pratama Putra
{"title":"比较激光解剖内镜下前列腺摘除(LAEEP)和经尿道前列腺切除术(TURP)治疗前列腺增生症的疗效:一项荟萃分析","authors":"Dimas B. Kresna Yustisia Handoyo ,&nbsp;Boyke Soebhali ,&nbsp;Widiyanto Prasetyawan ,&nbsp;Probo Yudha Pratama Putra","doi":"10.1016/j.urine.2022.08.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Laser anatomical endoscopic enucleation of the prostate (LAEEP) is one of the alternative surgical procedures other than TURP for benign prostate hyperplasia (BPH). However, the consideration for clinical practice needs evidence in terms of efficacy and safety. Our meta-analysis based on the existing studies is to evaluate the efficacy and safety of the LAEEP and TURP for BPH treatment.</p></div><div><h3>Materials and methods</h3><p>Published randomized controlled trials (RCTs) were identified from PubMed, Science Direct, and Cochrane Library up to December 2021. The meta-analysis was performed by the requirements of PRISMA and after methodological quality assessment, the data was proceeded by RevMan V.5.4.</p></div><div><h3>Results</h3><p>15 studies were identified with total of 733 patients who underwent LAEEP and 698 patients underwent TURP. There was no significant difference in IPSS at 1,3,6 month but at 12 months significantly better in LAEEP (MD ​= ​−0.43 [-0.81, −0.05] P ​= ​0.03). At 6 and 12 months, the PVR data showed significantly lower in LAEEP (MD ​= ​−4.07 [-6.07, −2.07] P ​&lt; ​0.0001). QoL, Qmax, and IIEF-5 scores were no significant difference in both procedures. Duration of catheterization (MD ​= ​−25.01 [-30.47, −19.55] P ​= ​0.00001) and hospital stay (MD ​= ​−30.26 [-40.71, −19.82] P ​= ​0,00001) were significantly shorter in LAEEP. Operative duration was significantly shorter in TURP (MD ​= ​14.69 [8.64, 20.75] P ​= ​0.00001) but prostate specimen weight result was significantly higher in LAEEP procedure (MD ​= ​4.77 [0.36, 9.17] P ​= ​0.03). Hb drop level (MD ​= ​−0.58 [-0.85, −0.30] P ​= ​0.0001), transfusion rate (OR ​= ​0.37 [0.17, 0.84] P ​= ​0.02) and UTI (OR ​= ​0.35 [0.17, 0.71] P ​= ​0.004) were significantly fewer in LAEEP. However, dysuria events less occurred in TURP (OR ​= ​2.45 [1.51, 3.97] P ​= ​0.0003).</p></div><div><h3>Conclusion</h3><p>Compared with TURP, LAEEP showed better efficacy and safety with fewer hematological changes and complications, except for operative duration, dysuria events were better in TURP. LAEEP showed other advantages in shorter catheterization time and hospital stay.</p></div>","PeriodicalId":75287,"journal":{"name":"Urine (Amsterdam, Netherlands)","volume":"4 ","pages":"Pages 15-24"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590280622000079/pdfft?md5=7e5471a30939224bcf1d88ebfb7504a6&pid=1-s2.0-S2590280622000079-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Comparison laser anatomical endoscopic enucleation of the prostate (LAEEP) and transurethral resection of the prostate (TURP) in BPH treatment: A meta-analysis\",\"authors\":\"Dimas B. Kresna Yustisia Handoyo ,&nbsp;Boyke Soebhali ,&nbsp;Widiyanto Prasetyawan ,&nbsp;Probo Yudha Pratama Putra\",\"doi\":\"10.1016/j.urine.2022.08.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Laser anatomical endoscopic enucleation of the prostate (LAEEP) is one of the alternative surgical procedures other than TURP for benign prostate hyperplasia (BPH). However, the consideration for clinical practice needs evidence in terms of efficacy and safety. Our meta-analysis based on the existing studies is to evaluate the efficacy and safety of the LAEEP and TURP for BPH treatment.</p></div><div><h3>Materials and methods</h3><p>Published randomized controlled trials (RCTs) were identified from PubMed, Science Direct, and Cochrane Library up to December 2021. The meta-analysis was performed by the requirements of PRISMA and after methodological quality assessment, the data was proceeded by RevMan V.5.4.</p></div><div><h3>Results</h3><p>15 studies were identified with total of 733 patients who underwent LAEEP and 698 patients underwent TURP. There was no significant difference in IPSS at 1,3,6 month but at 12 months significantly better in LAEEP (MD ​= ​−0.43 [-0.81, −0.05] P ​= ​0.03). At 6 and 12 months, the PVR data showed significantly lower in LAEEP (MD ​= ​−4.07 [-6.07, −2.07] P ​&lt; ​0.0001). QoL, Qmax, and IIEF-5 scores were no significant difference in both procedures. Duration of catheterization (MD ​= ​−25.01 [-30.47, −19.55] P ​= ​0.00001) and hospital stay (MD ​= ​−30.26 [-40.71, −19.82] P ​= ​0,00001) were significantly shorter in LAEEP. Operative duration was significantly shorter in TURP (MD ​= ​14.69 [8.64, 20.75] P ​= ​0.00001) but prostate specimen weight result was significantly higher in LAEEP procedure (MD ​= ​4.77 [0.36, 9.17] P ​= ​0.03). Hb drop level (MD ​= ​−0.58 [-0.85, −0.30] P ​= ​0.0001), transfusion rate (OR ​= ​0.37 [0.17, 0.84] P ​= ​0.02) and UTI (OR ​= ​0.35 [0.17, 0.71] P ​= ​0.004) were significantly fewer in LAEEP. However, dysuria events less occurred in TURP (OR ​= ​2.45 [1.51, 3.97] P ​= ​0.0003).</p></div><div><h3>Conclusion</h3><p>Compared with TURP, LAEEP showed better efficacy and safety with fewer hematological changes and complications, except for operative duration, dysuria events were better in TURP. LAEEP showed other advantages in shorter catheterization time and hospital stay.</p></div>\",\"PeriodicalId\":75287,\"journal\":{\"name\":\"Urine (Amsterdam, Netherlands)\",\"volume\":\"4 \",\"pages\":\"Pages 15-24\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590280622000079/pdfft?md5=7e5471a30939224bcf1d88ebfb7504a6&pid=1-s2.0-S2590280622000079-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urine (Amsterdam, Netherlands)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590280622000079\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urine (Amsterdam, Netherlands)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590280622000079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

激光解剖内镜下前列腺摘除(LAEEP)是除TURP外治疗良性前列腺增生(BPH)的另一种外科手术方法。然而,临床实践的考虑需要在有效性和安全性方面的证据。我们在现有研究的基础上进行荟萃分析,以评估LAEEP和TURP治疗BPH的有效性和安全性。材料和方法从PubMed、Science Direct和Cochrane Library检索到截至2021年12月的已发表的随机对照试验(RCTs)。meta分析按照PRISMA的要求进行,在方法学质量评估后,使用RevMan V.5.4对数据进行处理。结果15项研究共纳入733例LAEEP患者和698例TURP患者。IPSS在1、3、6个月时无显著差异,但LAEEP在12个月时显著改善(MD = - 0.43 [-0.81, - 0.05] P = 0.03)。在6个月和12个月时,PVR数据显示LAEEP显著降低(MD = - 4.07 [-6.07, - 2.07] P <0.0001)。两种治疗方法的QoL、Qmax和IIEF-5评分无显著差异。LAEEP患者的置管时间(MD = - 25.01 [-30.47, - 19.55] P = 0.00001)和住院时间(MD = - 30.26 [-40.71, - 19.82] P = 0.00001)均显著缩短。TURP组的手术时间明显缩短(MD = 14.69 [8.64, 20.75] P = 0.00001),而LAEEP组的前列腺标本重量明显增加(MD = 4.77 [0.36, 9.17] P = 0.03)。Hb水平下降(MD =−0.58(-0.85−0.30)P = 0.0001),输血率(或= 0.37 [0.17,0.84]P = 0.02)和泌尿道感染(或= 0.35 [0.17,0.71]P = 0.004)在LAEEP显著减少。而TURP患者排尿困难事件较少(OR = 2.45 [1.51, 3.97] P = 0.0003)。结论与TURP相比,LAEEP具有更好的疗效和安全性,血液学变化和并发症较少,除手术时间外,TURP的排尿困难事件较少。LAEEP在缩短置管时间和住院时间方面具有其他优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Comparison laser anatomical endoscopic enucleation of the prostate (LAEEP) and transurethral resection of the prostate (TURP) in BPH treatment: A meta-analysis

Introduction

Laser anatomical endoscopic enucleation of the prostate (LAEEP) is one of the alternative surgical procedures other than TURP for benign prostate hyperplasia (BPH). However, the consideration for clinical practice needs evidence in terms of efficacy and safety. Our meta-analysis based on the existing studies is to evaluate the efficacy and safety of the LAEEP and TURP for BPH treatment.

Materials and methods

Published randomized controlled trials (RCTs) were identified from PubMed, Science Direct, and Cochrane Library up to December 2021. The meta-analysis was performed by the requirements of PRISMA and after methodological quality assessment, the data was proceeded by RevMan V.5.4.

Results

15 studies were identified with total of 733 patients who underwent LAEEP and 698 patients underwent TURP. There was no significant difference in IPSS at 1,3,6 month but at 12 months significantly better in LAEEP (MD ​= ​−0.43 [-0.81, −0.05] P ​= ​0.03). At 6 and 12 months, the PVR data showed significantly lower in LAEEP (MD ​= ​−4.07 [-6.07, −2.07] P ​< ​0.0001). QoL, Qmax, and IIEF-5 scores were no significant difference in both procedures. Duration of catheterization (MD ​= ​−25.01 [-30.47, −19.55] P ​= ​0.00001) and hospital stay (MD ​= ​−30.26 [-40.71, −19.82] P ​= ​0,00001) were significantly shorter in LAEEP. Operative duration was significantly shorter in TURP (MD ​= ​14.69 [8.64, 20.75] P ​= ​0.00001) but prostate specimen weight result was significantly higher in LAEEP procedure (MD ​= ​4.77 [0.36, 9.17] P ​= ​0.03). Hb drop level (MD ​= ​−0.58 [-0.85, −0.30] P ​= ​0.0001), transfusion rate (OR ​= ​0.37 [0.17, 0.84] P ​= ​0.02) and UTI (OR ​= ​0.35 [0.17, 0.71] P ​= ​0.004) were significantly fewer in LAEEP. However, dysuria events less occurred in TURP (OR ​= ​2.45 [1.51, 3.97] P ​= ​0.0003).

Conclusion

Compared with TURP, LAEEP showed better efficacy and safety with fewer hematological changes and complications, except for operative duration, dysuria events were better in TURP. LAEEP showed other advantages in shorter catheterization time and hospital stay.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Urine (Amsterdam, Netherlands)
Urine (Amsterdam, Netherlands) Health Informatics, Pathology and Medical Technology, Urology
自引率
0.00%
发文量
0
审稿时长
99 days
期刊最新文献
In addition to early biomarkers, what else can be done with urine? CreCENT: Creatinine and Chloride based Electrochemical Non-faradaic renal health mapping Technology A facile strategy for comprehensive proteome analysis of urine using ultracentrifugation fractionation, solid-phase alkylation based sample preparation and liquid chromatography-mass spectrometry A new HPLC-MS/MS method for urinary creatinine determination: Comparison study with Jaffè’s method A review on traditional natural compounds and conventional methods for the treatment of UTI
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1